FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Front Vet Sci / Role of cannabidiolic acid or the combination of cannabigero...
Frontiers in veterinary science2024; 11; 1496473; doi: 10.3389/fvets.2024.1496473

Role of cannabidiolic acid or the combination of cannabigerol/cannabidiol in pain modulation and welfare improvement in horses with chronic osteoarthritis.

Abstract: Cannabidiol (CBD) is a non-psychotropic cannabinoid obtained from hemp (Cannabis sativa L.) used for pain management in companion animals including horses. The present study aimed to evaluate the efficacy of cannabidiolic acid (CBDA) and cannabigerol/cannabidiol oil (CBG/CBD) oral administration in alleviating pain in adult horses affected by chronic osteoarthritis (OA). Twenty-four horses (10 geldings and 14 mares), aged between 11 and 18 years old, were equally divided into two groups. One group received CBDA 15% oil and the other group received CBG/CBD oil (CBG20%-CBD10%) for 14 consecutive days. A standard dose of 0.07 mg/kg was chosen based on the mean body weight of 450 ± 28 kg. Horse Chronic Pain Scale (HCPS) and physiological parameters monitoring heart rate (HR), respiratory rate (RR), arterial blood pressure (systolic arterial pressure- SAP, diastolic arterial pressure- DAP) were assessed before (T0) and every day for the entire administration (T1-T14). Blood samples were collected for the evaluation of complete hemogram, Leukocyte subpopulation identification and counting and leukocyte differentiation antigens CD4 and CD8 at the day before the administration (T0) and every 7 days (T7 and T14). A reduction of HCPS pain scale scores and the number of WBC, monocytes and neutrophils and CD8 was observed with both CBDA and CBG/CBD treatment. No statistical differences were found in the physiological parameters. No subject required rescue analgesia or showed any adverse effects. The results of this study showed that oral administration of both CBDA and CBG/CBD oil may promote pain reduction in adult horses affected by chronic OA.
Copyright © 2024 Aragona, Tabbì, Gugliandolo, Giannetto, D’Angelo, Fazio and Interlandi.
Get Full Text
Publication Date: 2024-12-10 PubMed ID: 39720409PubMed Central: PMC11668182DOI: 10.3389/fvets.2024.1496473Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This study evaluated the effectiveness of specific cannabis-derived compounds in alleviating pain associated with chronic osteoarthritis in adult horses. The results show that oral administration of cannabidiolic acid and a combination of cannabigerol/cannabidiol oil may help in reducing pain in horses diagnosed with this condition.

Understanding the Study

In this research:

  • The researchers studied the efficacy of two specific cannabis-derived compounds: cannabidiolic acid (CBDA) and a combination of cannabigerol and cannabidiol (CBG/CBD) oil in relieving pain associated with chronic osteoarthritis (OA) in horses.
  • The study was conducted on 24 horses aged between 11 to 18 years old, with 10 geldings and 14 mares. These horses were equally divided into two groups: one group received CBDA 15% oil and the other received CBG/CBD oil with a composition of 20% CBG and 10% CBD for 14 consecutive days.
  • These compounds were administered orally at a standard dose calculated based on a mean body weight of 450 kg, with the dosage being 0.07 mg/kg of body weight.

Measurements and Observations

The following aspects were assessed during the study:

  • The Horse Chronic Pain Scale (HCPS), and physiological parameters such as heart rate, respiratory rate, systolic arterial pressure and diastolic arterial pressure were monitored daily.
  • Blood samples were collected for the evaluation of complete hemogram, leukocyte subpopulation identification and counting, and leukocyte differentiation antigens CD4 and CD8 on the day before the administration started and thereafter on days 7 and 14.
  • A decrease in the HCPS pain scale scores, the number of white blood cells (WBC), monocytes, and neutrophils, as well as the CD8 antigen was observed in association with both CBDA and CBG/CBD treatment.
  • No apparent changes were observed in the measured physiological parameters.

Key Outcomes and Implications

Based on their observations, researchers concluded:

  • Both CBDA and CBG/CBD did not cause any adverse effects, and no horse required any form of rescue analgesia, indicating that these treatments were well-tolerated and safe.
  • The oral administration of both CBDA and CBG/CBD oil showed potential in promoting pain reduction in adult horses affected by chronic osteoarthritis.
  • This finding suggests possibilities for implementing alternative treatments in veterinary medicine, specifically for pain related to chronic conditions such as OA in horses. Nonetheless, further research is needed to understand the precise mechanisms and potential long-term effects.

Cite This Article

APA
Aragona F, Tabbì M, Gugliandolo E, Giannetto C, D'Angelo F, Fazio F, Interlandi C. (2024). Role of cannabidiolic acid or the combination of cannabigerol/cannabidiol in pain modulation and welfare improvement in horses with chronic osteoarthritis. Front Vet Sci, 11, 1496473. https://doi.org/10.3389/fvets.2024.1496473

Publication

Frontiers in veterinary science
ISSN: 2297-1769
NlmUniqueID: 101666658
Country: Switzerland
Language: English
Volume: 11
Pages: 1496473

Researcher Affiliations

Aragona, Francesca
  • Department of Veterinary Sciences, University of Messina, Messina, Italy.
Tabbì, Marco
  • Department of Veterinary Sciences, University of Messina, Messina, Italy.
Gugliandolo, Enrico
  • Department of Veterinary Sciences, University of Messina, Messina, Italy.
Giannetto, Claudia
  • Department of Veterinary Sciences, University of Messina, Messina, Italy.
D'Angelo, Fabiola
  • Independent Practitioner, Varese, Italy.
Fazio, Francesco
  • Department of Veterinary Sciences, University of Messina, Messina, Italy.
Interlandi, Claudia
  • Department of Veterinary Sciences, University of Messina, Messina, Italy.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

References

This article includes 59 references
  1. Reis IL, Lopes B, Sousa P, Sousa AC, Caseiro AR, Mendonça CM. Equine musculoskeletal pathologies: clinical approaches and therapeutical perspectives-a review. Vet Sci (2024) 11:190.
    doi: 10.3390/vetsci11050190pmc: PMC11126110pubmed: 38787162google scholar: lookup
  2. Rogers CW, Bolwell CF, Gee EK, Rosanowski SM. Equine musculoskeletal development and performance: impact of the production system and early training. Anim Prod Sci (2020) 60:2069–79.
    doi: 10.1071/AN17685google scholar: lookup
  3. McIlwraith CW, Frisbie DD, Kawcak CE. The horse as a model of naturally occurring osteoarthritis. Bone Joint Res (2012) 1:297–309.
    doi: 10.1302/2046-3758.111.2000132pmc: PMC3626203pubmed: 23610661google scholar: lookup
  4. Souza MV. Osteoarthritis in horses - part 1: relationship between clinical and radiographic examination for the diagnosis. Braz Arch Biol Technol (2016) 59:1–9.
    doi: 10.1590/1678-4324-2016150024google scholar: lookup
  5. Kidd JA, Fuller C, Barr ARS. Osteoarthritis in the horse. Equine Vet Educ (2001) 13:160–8.
    doi: 10.1111/j.2042-3292.2001.tb00082.xgoogle scholar: lookup
  6. Goodrich LR, Nixon AJ. Medical treatment of osteoarthritis in the horse - a review. Vet J (2006) 171:51–69.
    doi: 10.1016/j.tvjl.2004.07.008pubmed: 16427582google scholar: lookup
  7. Michalska J, Nowicka B, Wessely-Szponder J. Relationship between neutrophil activity, oxidative stress, acute phase response, and lameness grade in naturally occurring acute and chronic joint disorders in horses. J Equine Vet (2020) 88:102972.
    doi: 10.1016/j.jevs.2020.102972pubmed: 32303320google scholar: lookup
  8. Ferris DJ, Frisbie DD, McIlwraith CW, Kawcak CE. Current joint therapy usage in equine practice: a survey of veterinarians 2009. Equine Vet J (2011) 43:530–5.
    doi: 10.1111/j.2042-3306.2010.00324.xpubmed: 21668486google scholar: lookup
  9. Isola M, Piccinotti C, Magro M, Fasolato L, Vianello F, Menandro ML. Colloidal Iron oxide formulation for equine hoof disinfection. Animals (2021) 11:766.
    doi: 10.3390/ani11030766pmc: PMC8000413pubmed: 33801981google scholar: lookup
  10. Mercer MA, Davis JL, McKenzie HC. The clinical pharmacology and therapeutic evaluation of non-steroidal anti-inflammatory drugs in adult horses. Animals (2023) 13:1597.
    doi: 10.3390/ani13101597pmc: PMC10215112pubmed: 37238029google scholar: lookup
  11. Flood J, Stewart AJ. Non-steroidal anti-inflammatory drugs and associated toxicities in horses. Animals (2022) 26) 12:2939.
    doi: 10.3390/ani1221293pmc: PMC9655344pubmed: 36359062google scholar: lookup
  12. Bushlin I, Rozenfeld R, Devi LA. Cannabinoid-opioid interactions during neuropathic pain and analgesia. Curr Opin Pharmacol (2010) 10:80–6.
    doi: 10.1016/j.coph.2009.09.009pmc: PMC2818338pubmed: 19857996google scholar: lookup
  13. Ellis K, Contino E. Treatment using cannabidiol in a horse with mechanical allodynia. Equine Vet Educ (2019) 33.
    doi: 10.1111/eve.13168google scholar: lookup
  14. Miranda-Cortés A, Mota-Rojas D, Crosignani-Outeda N, Casas-Alvarado A, Martínez-Burnes J, Olmos-Hernández A. The role of cannabinoids in pain modulation in companion animals. Front Vet Sci (2023) 9:1050884.
    doi: 10.3389/fvets.2022.1050884pmc: PMC9848446pubmed: 36686189google scholar: lookup
  15. Andre CM, Hausman JF, Guerriero G. Cannabis sativa: the plant of the thousand and one molecules. Front Plant Sci (2016) 7:19.
    doi: 10.3389/fpls.2016.00019pmc: PMC4740396pubmed: 26870049google scholar: lookup
  16. De Briyne N, Holmes D, Sandler I, Stiles E, Szymanski D, Moody S. Cannabis, cannabidiol oils and tetrahydrocannabinol-what do veterinarians need to know?. Animals (2021) 11:892.
    doi: 10.3390/ani11030892pmc: PMC8003882pubmed: 33804793google scholar: lookup
  17. Mlost J, Bryk M, Starowicz K. Cannabidiol for pain treatment: focus on pharmacology and mechanism of action. Int J Mol Sci (2020) 21:8870.
    doi: 10.3390/ijms21228870pmc: PMC7700528pubmed: 33238607google scholar: lookup
  18. Brioschi FA, Di Cesare F, Gioeni D, Rabbogliatti V, Ferrari F, D'Urso ES. Oral Transmucosal Cannabidiol oil formulation as part of a multimodal analgesic regimen: effects on pain relief and quality of life improvement in dogs affected by spontaneous osteoarthritis. Animals (2020) 10:1505.
    doi: 10.3390/ani10091505pmc: PMC7552307pubmed: 32858828google scholar: lookup
  19. Pacher P, Bátkai S, Kunos G. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev (2006) 58:389–462.
    doi: 10.1124/pr.58.3.2pmc: PMC2241751pubmed: 16968947google scholar: lookup
  20. Corsetti S, Borruso S, Malandrucco L, Spallucci V, Maragliano L, Perino R. Cannabis sativa L. may reduce aggressive behaviour towards humans in shelter dogs. Sci Rep (2021) 11:2773.
    doi: 10.1038/s41598-021-82439-2pmc: PMC7854708pubmed: 33531559google scholar: lookup
  21. Zhornitsky S, Potvin S. Cannabidiol in humans-the quest for therapeutic targets. Pharmaceuticals (2012) 5:529–52.
    doi: 10.3390/ph5050529pmc: PMC3763649pubmed: 24281562google scholar: lookup
  22. Genovese T, Cordaro M, Siracusa R, Impellizzeri D, Caudullo S, Raffone E. Molecular and biochemical mechanism of Cannabidiol in the Management of the Inflammatory and Oxidative Processes Associated with endometriosis. Int J Mol Sci (2022) 23:5427.
    doi: 10.3390/ijms23105427pmc: PMC9141153pubmed: 35628240google scholar: lookup
  23. Leise JM, Leatherwood JL, Paris BL, Walter KW, George JM, Martinez RE. Evaluation of an Oral supplemental Cannabidiol product for acceptability and performance in mature horses. Animals (2023) 13:401.
    doi: 10.3390/ani13020245pmc: PMC9854761pubmed: 36670785google scholar: lookup
  24. Thomson ACS, McCarrel TM, Zakharov A, Gomez B, Lyubimov A, Schwark WS. Pharmacokinetics and tolerability of single-dose enteral cannabidiol and cannabidiolic acid rich hemp in horses (Equus caballus). Front Vet Sci (2024) 11:1356463.
    doi: 10.3389/fvets.2024.1356463pmc: PMC11047043pubmed: 38681854google scholar: lookup
  25. Interlandi C, Tabbì M, Di Pietro S, D'Angelo F, Costa GL, Arfuso F. Improved quality of life and pain relief in mature horses with osteoarthritis after oral transmucosal cannabidiol oil administration as part of an analgesic regimen. Front Vet Sci (2024) 11:1341396.
    doi: 10.3389/fvets.2024.1341396pmc: PMC10876772pubmed: 38379920google scholar: lookup
  26. Kogan LR, Hellyer PW, Silcox S, Schoenfeld-Tacher R. Canadian dog owners’ use and perceptions of cannabis products. Can Vet J (2019) 60:749–55.
    pmc: PMC6563876pubmed: 31281193
  27. Ribeiro A, Ferraz-de-Paula V, Pinheiro ML, Vitoretti LB, Mariano-Souza DP, Quinteiro-Filho WM. Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: role for the adenosine A(2A) receptor. Eur J Pharmacol (2012) 678:78–85.
    doi: 10.1016/j.ejphar.2011.12.043pubmed: 22265864google scholar: lookup
  28. Turner S, Barker VD, Adams AA. Effects of cannabidiol on the in vitro lymphocyte pro-inflammatory cytokine production of senior horses. J Equine Vet (2021) 103:103668.
    doi: 10.1016/j.jevs.2021.103668pubmed: 34281647google scholar: lookup
  29. Nachnani R, Raup-Konsavage WM, Vrana KE. The pharmacological case for cannabigerol. J Pharmacol Exp Ther (2021) 376:204–12.
    doi: 10.1124/jpet.120.000340pubmed: 33168643google scholar: lookup
  30. Calapai F, Cardia L, Esposito E, Ammendolia I, Mondello C, Lo Giudice R. Pharmacological aspects and biological effects of cannabigerol and its synthetic derivatives. Evid Based Complement Alternat Med (2022) 2022:3336516–4.
    doi: 10.1155/2022/3336516pmc: PMC9666035pubmed: 36397993google scholar: lookup
  31. Lowin T, Tigges-Perez MS, Constant E, Pongratz G. Anti-inflammatory effects of Cannabigerol in rheumatoid arthritis synovial fibroblasts and peripheral blood mononuclear cell cultures are partly mediated by TRPA1. Int J Mol Sci (2023) 24:855.
    doi: 10.3390/ijms24010855pmc: PMC9820932pubmed: 36614296google scholar: lookup
  32. Formato M, Crescente G, Scognamiglio M, Fiorentino A, Pecoraro MT, Piccolella S. (−)-Cannabidiolic acid, a still overlooked bioactive compound: an introductory review and preliminary research. Molecules (2020) 25:2638.
    doi: 10.3390/molecules25112638pmc: PMC7321064pubmed: 32517131google scholar: lookup
  33. Landa L, Trojan V, Demlova R, Jurica J, Hrib R. Cannabidiol and the possibilities of its use in veterinary medicine of dogs and horses: a brief review. Vet Med (2022) 67.
    doi: 10.17221/127/2021pmc: PMC11071133pubmed: 38715968google scholar: lookup
  34. Coelho JC, Duarte N, Bento da Silva A, Bronze MR, Mestrinho LA. Placebo-controlled trial of daily oral cannabidiol as adjunctive treatment for cats with chronic gingivostomatitis. Animals (2023) 13:2716.
    doi: 10.3390/ani13172716pmc: PMC10487179pubmed: 37684980google scholar: lookup
  35. McGrath S, Bartner LR, Rao S, Packer RA, Gustafson DL. Randomized blinded controlled clinical trial to assess the effect of oral cannabidiol administration in addition to conventional antiepileptic treatment on seizure frequency in dogs with intractable idiopathic epilepsy. J Am Vet Med Assoc (2019) 254:1301–8.
    doi: 10.2460/javma.254.11.1301pubmed: 31067185google scholar: lookup
  36. Kleinhenz MD, Weeder M, Montgomery S, Martin M, Curtis A, Magnin G. Short term feeding of industrial hemp with a high cannabidiolic acid (CBDA) content increases lying behavior and reduces biomarkers of stress and inflammation in Holstein steers. Sci Rep (2022) 12:3683.
    doi: 10.1038/s41598-022-07795-zpmc: PMC8901777pubmed: 35256692google scholar: lookup
  37. Landa L, Sulcova A, Gbelec P. The use of cannabinoids in animals and therapeutic implications for veterinary medicine: a review. Vet Med (2016) 61:111–22.
    doi: 10.17221/8762-VETMEDgoogle scholar: lookup
  38. Atalay S, Jarocka-Karpowicz I, Skrzydlewska E. Antioxidative and anti-inflammatory properties of Cannabidiol. Antioxidants (2019) 9:21.
    doi: 10.3390/antiox9010021pmc: PMC7023045pubmed: 31881765google scholar: lookup
  39. Valastro C, Campanile D, Marinaro M, Franchini D, Piscitelli F, Verde R. Characterization of endocannabinoids and related acylethanolamides in the synovial fluid of dogs with osteoarthritis: a pilot study. BMC Vet Res (2017) 13:309.
    doi: 10.1186/s12917-017-1245-7pmc: PMC5674828pubmed: 29110674google scholar: lookup
  40. Gamble LJ, Boesch JM, Frye CW, Schwark WS, Mann S, Wolfe L. Pharmacokinetics, safety, and clinical efficacy of Cannabidiol treatment in osteoarthritic dogs. Front Vet Sci (2018) 5:165.
    doi: 10.3389/fvets.2018.00165pmc: PMC6065210pubmed: 30083539google scholar: lookup
  41. Ryan D, McKemie DS, Kass PH, Puschner B, Knych HK. Pharmacokinetics and effects on arachidonic acid metabolism of low doses of cannabidiol following oral administration to horses. Drug Test Anal (2021) 13:1305–17.
    doi: 10.1002/dta.3028pubmed: 33723919google scholar: lookup
  42. van Loon JPAM, Macri L. Objective assessment of chronic pain in horses using the horse chronic pain scale (HCPS): a scale-construction study. Animals (2021) 11:1826.
    doi: 10.3390/ani11061826pmc: PMC8234780pubmed: 34207290google scholar: lookup
  43. van Loon JP, Jonckheer-Sheehy VS, Back W, van Weeren PR, Hellebrekers LJ. Monitoring equine visceral pain with a composite pain scale score and correlation with survival after emergency gastrointestinal surgery. Vet J (2014) 200:109–15.
    doi: 10.1016/j.tvjl.2014.01.003pubmed: 24491373google scholar: lookup
  44. Piccione G, Caola G, Refinetti R. Temporal relationships of 21 physiological variables in horse and sheep. Comp Biochem Physiol A Mol Integr Physiol (2005) 142:389–96.
    doi: 10.1016/j.cbpa.2005.07.019pubmed: 16290083google scholar: lookup
  45. Aragona F, Arfuso F, Fazio F, De Caro S, Giudice E, Monteverde V. Circadian variation of peripheral blood cells in horses maintained in different environmental and management conditions. Animals (2023) 13:1865.
    doi: 10.3390/ani13111865pmc: PMC10251899pubmed: 37889772google scholar: lookup
  46. de Grauw JC, van Loon JP. Systematic pain assessment in horses. Vet J (2016) 209:14–22.
    doi: 10.1016/j.tvjl.2015.07.030pubmed: 26831169google scholar: lookup
  47. Bussières G, Jacques C, Lainay O, Beauchamp G, Leblond A, Cadoré JL. Development of a composite orthopaedic pain scale in horses. Res Vet Sci (2008) 85:294–306.
    doi: 10.1016/j.rvsc.2007.10.011pubmed: 18061637google scholar: lookup
  48. Robaina Cabrera CL, Keir-Rudman S, Horniman N, Clarkson N, Page C. The anti-inflammatory effects of cannabidiol and cannabigerol alone, and in combination. Pulm Pharmacol Ther (2021) 69:102047.
    doi: 10.1016/j.pupt.2021.102047pubmed: 34082108google scholar: lookup
  49. von Lewinski M, Biau S, Erber R, Ille N, Aurich J, Faure JM. Cortisol release, heart rate and heart rate variability in the horse and its rider: different responses to training and performance. Vet J (2013) 197:229–32.
    doi: 10.1016/j.tvjl.2012.12.025pubmed: 23380228google scholar: lookup
  50. Eichler F, Poźniak B, Machnik M, Schenk I, Wingender A, Baudisch N. Pharmacokinetic modelling of orally administered cannabidiol and implications for medication control in horses. Front Vet Sci (2023) 10:1234551.
    doi: 10.3389/fvets.2023.1234551pmc: PMC10445762pubmed: 37621871google scholar: lookup
  51. Resstel LB, Tavares RF, Lisboa SF, Joca SR, Corrêa FM, Guimarães FS. 5-HT1A receptors are involved in the cannabidiol-induced attenuation of behavioural and cardiovascular responses to acute restraint stress in rats. Br J Pharmacol (2009) 156:181–8.
    doi: 10.1111/j.1476-5381.2008.00046.xpmc: PMC2697769pubmed: 19133999google scholar: lookup
  52. Williams NNB, Ewell TR, Abbotts KSS, Harms KJ, Woelfel KA, Dooley GP. Comparison of five Oral Cannabidiol preparations in adult humans: pharmacokinetics, body composition, and heart rate variability. Pharmaceuticals (2021) 14:35.
    doi: 10.3390/ph14010035pmc: PMC7825058pubmed: 33418866google scholar: lookup
  53. Benigni G, Dimitrova P, Antonangeli F, Sanseviero E, Milanova V, Blom A. CXCR3/CXCL10 Axis regulates neutrophil-NK cell cross-talk determining the severity of experimental osteoarthritis. J Immunol (2017) 198:2115–24.
    doi: 10.4049/jimmunol.1601359pubmed: 28108560google scholar: lookup
  54. Liu-Bryan R. Synovium and the innate inflammatory network in osteoarthritis progression. Curr Rheumatol Rep (2013) 15:323.
    doi: 10.1007/s11926-013-0323-5pmc: PMC3643293pubmed: 23516014google scholar: lookup
  55. Li M, Yin H, Yan Z, Li H, Wu J, Wang Y. The immune microenvironment in cartilage injury and repair. Acta Biomater (2022) 140:23–42.
    doi: 10.1016/j.actbio.2021.12.006pubmed: 34896634google scholar: lookup
  56. Soehnlein O, Steffens S, Hidalgo A, Weber C. Neutrophils as protagonists and targets in chronic inflammation. Nat Rev Immunol (2017) 17:248–61.
    doi: 10.1038/nri.2017.10pubmed: 28287106google scholar: lookup
  57. Baddack-Werncke U, Busch-Dienstfertig M, González-Rodríguez S, Maddila SC, Grobe J, Lipp M. Cytotoxic T cells modulate inflammation and endogenous opioid analgesia in chronic arthritis. J Neuroinflammation (2017) 14:30.
    doi: 10.1186/s12974-017-0804-ypmc: PMC5294766pubmed: 28166793google scholar: lookup
  58. Gugliandolo E, Licata P, Peritore AF, Siracusa R, D'Amico R, Cordaro M. Effect of Cannabidiol (CBD) on canine inflammatory response: an ex vivo study on LPS stimulated whole blood. Vet Sci (2021) 8:185.
    doi: 10.3390/vetsci8090185pmc: PMC8473042pubmed: 34564578google scholar: lookup
  59. Mehrani Y, Junqani R, Morovati S, Mehrani H, Karimi N, Ghasemi S. The importance of neutrophils in osteoarthritis: current concepts and therapeutic perspectives. Immuno (2023) 3:250–72.
    doi: 10.3390/immuno3030017google scholar: lookup
Subscribe to our newsletter
Join 99,359 horse owners like you who receive our email updates on horse health and nutrition.